Biotechnology Mycoplasma Testing Market Forecast ...

Mycoplasma Testing Market Forecast to 2028 - Covid-19 Impact and Global Analysis - by Product & Service (Kits & Reagents, Instruments and Services); Application (Cell Line Testing, Virus Testing, End-Of-Production Cell Testing and Other Applications); End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic Research Institutes and Other End Users), and Geography

Report Code: TIPRE00003516 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION
Testing for mycoplasma contamination is an essential practice in the process of cell culturing. Mycoplasma are small, simple bacteria, they represent one of the most prevalent and serious sources of cell line contamination. Since, these organisms lack a cell wall, they have a rapid mode of infecting the entire cell culture, causing loss on a large scale. Hence, in order to obtain better results, various companies have been providing solutions for testing mycoplasma contamination.

MARKET DYNAMICS
The mycoplasma testing market is anticipated to grow in the forecast, owing to increasing support and growth opportunity provided by biotechnology as well as the pharmaceutical industry, along with strong R&D investments in life sciences. In addition, increasing pharmaceutical outsourcing is expected to offer significant growth opportunities in the market during the forecast period.

MARKET SCOPE
The "Global Mycoplasma Testing Market Analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of mycoplasma testing market with detailed market segmentation by product & services, application, end user, and geography. The global mycoplasma testing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading mycoplasma testing market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global mycoplasma testing market is segmented on the basis of product & services, application and end user. Based on product & services, the market is segmented as kits & reagents, instruments and services. On the basis of application, the global mycoplasma testing market is segmented into, cell line testing, virus testing, end-of-production cell testing and other applications. Similarly, based on end user, the market is categorized as, pharmaceutical and biotechnology companies, contract research organizations, academic research institutes and other end users

Get more information on this report :


REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global mycoplasma testing market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The mycoplasma testing market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting mycoplasma testing market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the mycoplasma testing market in these regions.

Get more information on this report :

MARKET PLAYERS
The reports cover key developments in the mycoplasma testing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from mycoplasma testing market are anticipated to lucrative growth opportunities in the future with the rising demand for mycoplasma testing market in the global market. Below mentioned is the list of few companies engaged in the mycoplasma testing market.

The report also includes the profiles of key mycoplasma testing market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Agilent Technologies, Inc.
  • Charles River
  • Eurofins Scientific
  • F. Hoffmann-La Roche Ltd
  • Lonza
  • Merck KGaA
  • Minerva Biolabs
  • Sartorius AG
  • SGS SA
  • Thermo Fisher Scientific Inc.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Mycoplasma Testing Market - By Product & Service
1.3.2 Mycoplasma Testing Market - By Application
1.3.3 Mycoplasma Testing Market - By End User
1.3.4 Mycoplasma Testing Market - By Region
1.3.4.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. MYCOPLASMA TESTING MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. MYCOPLASMA TESTING MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. MYCOPLASMA TESTING MARKET - GLOBAL MARKET ANALYSIS
6.1. MYCOPLASMA TESTING - GLOBAL MARKET OVERVIEW
6.2. MYCOPLASMA TESTING - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. MYCOPLASMA TESTING MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT & SERVICE
7.1. OVERVIEW
7.2. PRODUCT & SERVICE MARKET FORECASTS AND ANALYSIS
7.3. KITS & REAGENTS
7.3.1. Overview
7.3.2. Kits & Reagents Market Forecast and Analysis
7.4. INSTRUMENTS
7.4.1. Overview
7.4.2. Instruments Market Forecast and Analysis
7.5. SERVICES
7.5.1. Overview
7.5.2. Services Market Forecast and Analysis
8. MYCOPLASMA TESTING MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. CELL LINE TESTING
8.3.1. Overview
8.3.2. Cell Line Testing Market Forecast and Analysis
8.4. VIRUS TESTING
8.4.1. Overview
8.4.2. Virus Testing Market Forecast and Analysis
8.5. END-OF-PRODUCTION CELL TESTING
8.5.1. Overview
8.5.2. End-Of-Production Cell Testing Market Forecast and Analysis
8.6. OTHER APPLICATIONS
8.6.1. Overview
8.6.2. Other Applications Market Forecast and Analysis
9. MYCOPLASMA TESTING MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
9.3.1. Overview
9.3.2. Pharmaceutical and Biotechnology Companies Market Forecast and Analysis
9.4. CONTRACT RESEARCH ORGANIZATIONS
9.4.1. Overview
9.4.2. Contract Research Organizations Market Forecast and Analysis
9.5. ACADEMIC RESEARCH INSTITUTES
9.5.1. Overview
9.5.2. Academic Research Institutes Market Forecast and Analysis
9.6. OTHER END USERS
9.6.1. Overview
9.6.2. Other End Users Market Forecast and Analysis
10. MYCOPLASMA TESTING MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Mycoplasma Testing Market Overview
10.1.2 North America Mycoplasma Testing Market Forecasts and Analysis
10.1.3 North America Mycoplasma Testing Market Forecasts and Analysis - By Product & Service
10.1.4 North America Mycoplasma Testing Market Forecasts and Analysis - By Application
10.1.5 North America Mycoplasma Testing Market Forecasts and Analysis - By End User
10.1.6 North America Mycoplasma Testing Market Forecasts and Analysis - By Countries
10.1.6.1 United States Mycoplasma Testing Market
10.1.6.1.1 United States Mycoplasma Testing Market by Product & Service
10.1.6.1.2 United States Mycoplasma Testing Market by Application
10.1.6.1.3 United States Mycoplasma Testing Market by End User
10.1.6.2 Canada Mycoplasma Testing Market
10.1.6.2.1 Canada Mycoplasma Testing Market by Product & Service
10.1.6.2.2 Canada Mycoplasma Testing Market by Application
10.1.6.2.3 Canada Mycoplasma Testing Market by End User
10.1.6.3 Mexico Mycoplasma Testing Market
10.1.6.3.1 Mexico Mycoplasma Testing Market by Product & Service
10.1.6.3.2 Mexico Mycoplasma Testing Market by Application
10.1.6.3.3 Mexico Mycoplasma Testing Market by End User
10.2. EUROPE
10.2.1 Europe Mycoplasma Testing Market Overview
10.2.2 Europe Mycoplasma Testing Market Forecasts and Analysis
10.2.3 Europe Mycoplasma Testing Market Forecasts and Analysis - By Product & Service
10.2.4 Europe Mycoplasma Testing Market Forecasts and Analysis - By Application
10.2.5 Europe Mycoplasma Testing Market Forecasts and Analysis - By End User
10.2.6 Europe Mycoplasma Testing Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Mycoplasma Testing Market
10.2.6.1.1 Germany Mycoplasma Testing Market by Product & Service
10.2.6.1.2 Germany Mycoplasma Testing Market by Application
10.2.6.1.3 Germany Mycoplasma Testing Market by End User
10.2.6.2 France Mycoplasma Testing Market
10.2.6.2.1 France Mycoplasma Testing Market by Product & Service
10.2.6.2.2 France Mycoplasma Testing Market by Application
10.2.6.2.3 France Mycoplasma Testing Market by End User
10.2.6.3 Italy Mycoplasma Testing Market
10.2.6.3.1 Italy Mycoplasma Testing Market by Product & Service
10.2.6.3.2 Italy Mycoplasma Testing Market by Application
10.2.6.3.3 Italy Mycoplasma Testing Market by End User
10.2.6.4 Spain Mycoplasma Testing Market
10.2.6.4.1 Spain Mycoplasma Testing Market by Product & Service
10.2.6.4.2 Spain Mycoplasma Testing Market by Application
10.2.6.4.3 Spain Mycoplasma Testing Market by End User
10.2.6.5 United Kingdom Mycoplasma Testing Market
10.2.6.5.1 United Kingdom Mycoplasma Testing Market by Product & Service
10.2.6.5.2 United Kingdom Mycoplasma Testing Market by Application
10.2.6.5.3 United Kingdom Mycoplasma Testing Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Mycoplasma Testing Market Overview
10.3.2 Asia-Pacific Mycoplasma Testing Market Forecasts and Analysis
10.3.3 Asia-Pacific Mycoplasma Testing Market Forecasts and Analysis - By Product & Service
10.3.4 Asia-Pacific Mycoplasma Testing Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Mycoplasma Testing Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Mycoplasma Testing Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Mycoplasma Testing Market
10.3.6.1.1 Australia Mycoplasma Testing Market by Product & Service
10.3.6.1.2 Australia Mycoplasma Testing Market by Application
10.3.6.1.3 Australia Mycoplasma Testing Market by End User
10.3.6.2 China Mycoplasma Testing Market
10.3.6.2.1 China Mycoplasma Testing Market by Product & Service
10.3.6.2.2 China Mycoplasma Testing Market by Application
10.3.6.2.3 China Mycoplasma Testing Market by End User
10.3.6.3 India Mycoplasma Testing Market
10.3.6.3.1 India Mycoplasma Testing Market by Product & Service
10.3.6.3.2 India Mycoplasma Testing Market by Application
10.3.6.3.3 India Mycoplasma Testing Market by End User
10.3.6.4 Japan Mycoplasma Testing Market
10.3.6.4.1 Japan Mycoplasma Testing Market by Product & Service
10.3.6.4.2 Japan Mycoplasma Testing Market by Application
10.3.6.4.3 Japan Mycoplasma Testing Market by End User
10.3.6.5 South Korea Mycoplasma Testing Market
10.3.6.5.1 South Korea Mycoplasma Testing Market by Product & Service
10.3.6.5.2 South Korea Mycoplasma Testing Market by Application
10.3.6.5.3 South Korea Mycoplasma Testing Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Mycoplasma Testing Market Overview
10.4.2 Middle East and Africa Mycoplasma Testing Market Forecasts and Analysis
10.4.3 Middle East and Africa Mycoplasma Testing Market Forecasts and Analysis - By Product & Service
10.4.4 Middle East and Africa Mycoplasma Testing Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Mycoplasma Testing Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Mycoplasma Testing Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Mycoplasma Testing Market
10.4.6.1.1 South Africa Mycoplasma Testing Market by Product & Service
10.4.6.1.2 South Africa Mycoplasma Testing Market by Application
10.4.6.1.3 South Africa Mycoplasma Testing Market by End User
10.4.6.2 Saudi Arabia Mycoplasma Testing Market
10.4.6.2.1 Saudi Arabia Mycoplasma Testing Market by Product & Service
10.4.6.2.2 Saudi Arabia Mycoplasma Testing Market by Application
10.4.6.2.3 Saudi Arabia Mycoplasma Testing Market by End User
10.4.6.3 U.A.E Mycoplasma Testing Market
10.4.6.3.1 U.A.E Mycoplasma Testing Market by Product & Service
10.4.6.3.2 U.A.E Mycoplasma Testing Market by Application
10.4.6.3.3 U.A.E Mycoplasma Testing Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Mycoplasma Testing Market Overview
10.5.2 South and Central America Mycoplasma Testing Market Forecasts and Analysis
10.5.3 South and Central America Mycoplasma Testing Market Forecasts and Analysis - By Product & Service
10.5.4 South and Central America Mycoplasma Testing Market Forecasts and Analysis - By Application
10.5.5 South and Central America Mycoplasma Testing Market Forecasts and Analysis - By End User
10.5.6 South and Central America Mycoplasma Testing Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Mycoplasma Testing Market
10.5.6.1.1 Brazil Mycoplasma Testing Market by Product & Service
10.5.6.1.2 Brazil Mycoplasma Testing Market by Application
10.5.6.1.3 Brazil Mycoplasma Testing Market by End User
10.5.6.2 Argentina Mycoplasma Testing Market
10.5.6.2.1 Argentina Mycoplasma Testing Market by Product & Service
10.5.6.2.2 Argentina Mycoplasma Testing Market by Application
10.5.6.2.3 Argentina Mycoplasma Testing Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. MYCOPLASMA TESTING MARKET, KEY COMPANY PROFILES
12.1. AGILENT TECHNOLOGIES, INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. CHARLES RIVER
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. EUROFINS SCIENTIFIC
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. F. HOFFMANN-LA ROCHE LTD
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. LONZA
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. MERCK KGAA
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. MINERVA BIOLABS
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. SARTORIUS AG
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. SGS SA
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. THERMO FISHER SCIENTIFIC INC.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Agilent Technologies, Inc.
2. Charles River
3. Eurofins Scientific
4. F. Hoffmann-La Roche Ltd
5. Lonza
6. Merck KGaA
7. Minerva Biolabs
8. Sartorius AG
9. SGS SA
10. Thermo Fisher Scientific Inc.
TIPRE00003516
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Contact Us : +1-646-491-9876 | +91-20-67271633 | Email : sales@theinsightpartners.com
© Copyright 2021 - The Insight Partners. All rights reserved